Article
TGF-β: An emerging player in drug resistance
15 Sept 2013
Abstract excerpt
The transforming growth factor β (TGF-β) pathway acts as a double-edged sword in tumorigenesis. By constraining epithelial cell growth, TGF-β is a potent tumor suppressor. However, TGF-β also acts as a key player in the induction of epithelial-to-mesenchymal transition (EMT), thereby enhancing invasiveness and metastasis. Furthermore, TGF-β signaling has recently been correlated with resistance against both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
